COVID-19

@forbes.com 4 years ago

Can Novavax Rise To The Manufacturing Challenge?

@WSJ 4 years ago

AstraZeneca said its Covid-19 vaccine was safe and 79% effective in U.S. trials and that it would prepare to request emergency-use authorization on.wsj.com

@abcnews.go.com 4 years ago

What to know about the Novavax COVID-19 vaccine

@forbes.com 4 years ago

Russia’s Sputnik V Vaccine Is 92% Effective Against Symptomatic Covid-19, Early Results Show, But There Are No Plans To Bring It To The U.S.

@forbes.com 4 years ago

Revised U.S. Trials Numbers Show AstraZeneca Vaccine Is 76% Effective Against Symptomatic Covid-19

@forbes.com 4 years ago

Johnson & Johnson Vaccine’s 66% Efficacy Figure Is Better Than It Looks

@forbes.com 4 years ago

AstraZeneca Vaccine 100% Effective In Preventing Severe Disease And Hospitalizations, U.S. Trials Show

@foxnews.com 5 years ago

Fauci tells House committee vaccine progress strong, blames states reopening early for coronavirus surge